bRIGHT study 1-year data card
Brief outline of the 1-year data outcomes from the bRIGHT study evaluating the safety and effectiveness of TriClip™ TEER in patients with severe TR in a real-world, post-market setting.
Related Resources
Review the Trends | Tricuspid focus
TAVI with Navitor Vision - Livecase
EuroPCR 2021: Advancing solutions for tricuspid regurgitation patients
ESC 2023 Tutorial – TriClip™ | Prof. Donal
EuroPCR 2022: Tendyne™
EACTS 2021: Transcatheter mitral valve implantation
TAVI Summit - Cardiac imaging
Echo course tricuspid TEER – patient selection